Flagship Pioneering Buys $50 M in Foghorn Therapeutics Warrants, Signaling Confidence in Its Oncology Pipeline
Flagship Pioneering’s $50 M warrant buy backs Foghorn’s pipeline, giving investors confidence in its oncology strategy and future upside.
3 minutes to read